XML 31 R6.htm IDEA: XBRL DOCUMENT v3.23.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities:    
Net loss $ (38,050) $ (34,058)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 795 833
Amortization of intangible asset 18,021 18,021
Non-cash interest expense related to sale of future royalties 0 4,428
Non-cash royalty revenue related to sale of future royalties (936) (764)
Non-cash collaboration revenue 0 (9,550)
Non-cash research and development expense 782 0
Non-cash interest expense 983 916
Non-cash operating lease expense (955) (1,198)
Non-cash write-off from termination of lease (825) 0
Write-down of inventory 612 7,430
Change in excess inventory purchase commitments 0 4,854
Stock-based compensation expense 5,979 11,453
Change in fair value of embedded debt derivative 0 (710)
Changes in operating assets and liabilities:    
Accounts receivable 20,712 (30,421)
Inventory 10,828 (4,362)
Prepaid expenses and other current assets 7,684 561
Other long-term assets (5,876) 10,012
Accounts payable (12,058) (8,807)
Accrued expense and other current liabilities (19,382) (19,464)
Operating lease liabilities 1,034 1,205
Deferred revenue (3,738) 5,963
Other long-term liabilities 481 (8,622)
Net cash used in operating activities (13,909) (52,280)
Investing Activities:    
Purchases of equipment 0 (114)
Net cash used in investing activities 0 (114)
Financing Activities:    
Proceeds from refund liabilities to customers 0 40,000
Proceeds from issuance of common stock, net of issuance costs 0 7,102
Proceeds from issuances of stock under employee stock purchase plan 34 367
Proceeds from the exercise of stock options 0 67
Repayments of term debt (24,000) 0
Net cash (used in) provided by financing activities (23,966) 47,536
Decrease in cash, cash equivalents and restricted cash (37,875) (4,858)
Cash, cash equivalents and restricted cash — beginning of period 93,169 151,839
Cash, cash equivalents and restricted cash — end of period $ 55,294 $ 146,981